跳至主要内容
临床试验/NCT00572260
NCT00572260终止4 期

A Pilot Study of Daptomycin for Antimicrobial Prophylaxis in Patients Undergoing Cardiac Valve Replacement and Coronary Artery Bypass Grafting (CABG) Who Are at Increased Risk for Infection Due to Methicillin-resistant Staphylococcus Aureus (MRSA)

Duke University1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2008年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
11
试验地点
1
主要终点
Rate of Patients Receiving Antimicrobial Prophylaxis Within the Appropriate Timeframe Before Incision

研究概览

简要总结

The goals of the study are to evaluate the feasibility of using daptomycin as a prophylactic antimicrobial agent in patients undergoing cardiac surgery, to determine the rates of surgical site infection, and to evaluate the occurrence of adverse events.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

A

Experimental

Daptomycin as a single preoperative dose within 30 minutes prior to surgery Dosage: if creatinine clearance ≥ 30 ml/min: 6 mg/kg IV

干预措施: daptomycin 6 mg/kg IV (Drug)

结局指标

主要结局

Rate of Patients Receiving Antimicrobial Prophylaxis Within the Appropriate Timeframe Before Incision

时间窗: 30 days after surgery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Pilot Study of Daptomycin for Antimicrobial... | 临床试验